Leachable
Multiple Sources
Leachables are organic or inorganic substances which are present in a drug product, they can have a wide range of sources. They are not direct synthetic or degradations impurities from the API but could be considered impurities. The most commonly considered source is the packaging system but in principle they could also be derived from any material which is in either direct or indirect contact with the drug product so they might include materials in the manufacturing system, devices used to deliver drug product or secondary and other packaging if the primary packaging is not a barrier.
It is also possible to define leachables as reaction products between the packaging system and formulation (API and/or excipients). Since they are generally considered to be any substance which is not either API, API or DP impurities or formulation excipients they can be a very wide collection of substances.
The concern is that these substances have the potential to risk drug product safety and/or drug product quality and could be dosed to patients.
From ISO10993-18
substances that are released from a medical device and to a potentially affected individual during its clinical use
From USP<1663>
are foreign organic and inorganic chemical entities that are present in a packaged drug product because they have leached into the packaged drug product from a packaging/delivery system, packaging component, or packaging material of construction under normal conditions of storage and use or during accelerated drug product stability studies. Because leachables are derived from the packaging or delivery system, they are not related to either the drug product itself or its vehicle and ingredients. Leachables are present in a packaged drug product because of the direct action of the drug product on the source of the leachable. Thus leachables are typically derived from primary and secondary packaging, as the primary and secondary packaging can serve as a barrier between the packaged drug product and other potential sources of foreign chemical entities (such as tertiary packaging and ancillary components). In certain circumstances, packaging may directly contact the patient under typical clinical conditions of use (for example, the mouthpiece of a metered dose Inhaler). As a result of this contact, patients may be exposed to leachables from the packaging without the action of the drug product. Leachables are typically a subset of extractables or are derived from extractables. |